September 27, 2021 - "Interplay Between FDA Law and Patent Law: Avoiding Indigestion After Belcher v. Hospira" (Schwegman Lundberg & Woessner) - 12:00 pm to 1:30 pm (CT)
September 28, 2021 - "Inventorship and Assignment: Two Vital Concepts in Patent Law" (Schwegman Lundberg & Woessner) - 12:00 pm (CT)
September 28, 2021 - "Mediation Programs and Other Forms of Alternative Dispute Resolution" (Federal Circuit Bar Association) - 3:00 pm to 4:00 pm (ET)
September 29, 2021 - "Patent Purgatory: How the USPTO Puts Patent Applications on Hold, and How One Inventor Is Fighting Back" (IPWatchdog) - 12:00 pm (ET)
September 29, 2021 - "112 Enablement: What to Watch Out For" (Biotechnology Innovation Organization IP Counsels Committee) - 1:00 pm (EDT)
September 29, 2021 - "IP Valuation" (International Intellectual Property Law Association) - 10:00 am to 11:00 am (PST)
September 29, 2021- "How to Litigate in the Western District of Texas" (Federal Circuit Bar Association) - 4:30 pm to 5:40 pm (ET)
September 29-30, 2021 - FDA Boot Camp (American Conference Institute)
September 30, 2021 - "China's New Patent Law: Explaining Substantial Changes Years in the Making" (IPWatchdog and AWA) - 10:00 am (ET)
September 30, 2021 - "China IP: Quarterly Legislation and Case Law Update" (U.S. Patent and Trademark Office) - 1:00 pm to 2:00 pm (ET)
October 5-21, 2021 - Hatch-Waxman and BPCIA Virtual Proficiency Series (American Conference Institute)
November 9-10, 2021 - Paragraph IV Disputes Conference (American Conference Institute) - 8:00 am until 6:00 pm (EST) on November 9 and 7:50 am until 5:15 pm (EST) on November 10, 2021
Comments